The proteasome inhibitor bortezomib enhances the activity of docetaxel in orthotopic human pancreatic tumor zenografts

Stefan T. Nawrocki, Bridget Sweeney-Gotsch, Ryan Takamori, David J. McConkey

Research output: Contribution to journalArticlepeer-review

117 Scopus citations

Fingerprint

Dive into the research topics of 'The proteasome inhibitor bortezomib enhances the activity of docetaxel in orthotopic human pancreatic tumor zenografts'. Together they form a unique fingerprint.

Medicine & Life Sciences